Myocardial IL-6 regulation by neurohormones - An in vitro superfusion study

Brain, Behavior, and Immunity

Volumn 17, Issue 4, 2003, Pages 245-250

  Jeron, Andreas ^a   Kaiser, Tanja ^a   Straub, Rainer H ^a   Weil, Joachim ^a   Riegger, Günter A J ^a   Muders, Frank ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Cytokines; IL 6; Immunoregulation; Myocardium; Superfusion

Indexed keywords

ANGIOTENSIN; CORTICOSTERONE; CYTOKINE; INTERLEUKIN 6; ISOPRENALINE; LIPOPOLYSACCHARIDE; NEUROHORMONE; STEROID;

ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; DRUG TARGETING; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART MUSCLE; HEART VENTRICLE; HORMONAL REGULATION; HORMONE DETERMINATION; IN VITRO STUDY; MALE; NEUROENDOCRINOLOGY; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TISSUE LEVEL; TISSUE SLICE;

EID: 0038047125     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-1591(03)00053-9     Document Type: Article

References (24)

1. Blum A., Miller H. Role of cytokines in heart failure. Am. Heart J. 135:1998;181-186.
2. Hirota H., Yoshida K., Kishimoto T., Taga T. Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. Proc. Natl. Acad. Sci. USA. 92:1995;4862-4866.
3. Jeron A., Straub R.H., Kaiser T., Riegger G.A.J., Muders F. Systemic immunosupression fails to suppress cardiac cytokine induction in pressure overload hypertrophy in rats. Immunobiology. 205:2002;51-60.
4. Kadokami T., McTiernan C.F., Kubota T., Frye C.S., Bounoutas G.S., Robbins P.D., Watkins S.C., Feldman A.M. Effects of soluble TNF receptor treatment on lipopolysaccharide-induced myocardial cytokine expression. Am. J. Physiol. Heart Circ. Physiol. 280:2001;H2281-H2291.
5. Kodama H., Fukuda K., Pan J., Sano M., Takahashi T., Kato T., Makino S., Manabe T., Murata M., Ogawa S. Significance of ERK cascade compared with JAK/STAT and PI3-K pathway in gp130-mediated cardiac hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 279(4):2000;H1635-H1644.
6. Kunisada K., Tone E., Fujio Y., Matsui H., Yamauchi-Takihara K., Kishimoto T. Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes. Circulation. 98:1998;346-352.
7. Lenzo J.C., Fairweather D., Shellam G.R., Lawson C.M. Immunomodulation of murine cytomegalovirus-induced myocarditis in mice treated with lipopolysaccharide and tumor necrosis factor. Cell. Immunol. 213:2001;52-61.
8. Levine B., Kalman J., Mayer L., Fillit H.M., Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N. Engl. J. Med. 318:1990;1481-1486.
9. Matsumori A., Ono K., Sato Y., Shioi T., Nose Y., Sasayama S. Differential modulation of cytokine production by drugs: Implications for therapy in heart failure. J. Mol. Cell. Cardiol. 28:1996;2491-2499.
10. Muller-Werdan U., Schumann H., Fuchs R., Reithmann C., Loppnow H., Koch S., Zimny-Arndt U., He C., Darmer D., Jungblut P., Stadler J., Holtz J., Werdan K. Tumor necrosis factor α (TNFα) is cardiodepressant in pathophysiologically relevant concentrations without inducing inducible nitric oxide-(NO)-synthase (iNOS) or triggering serious cytotoxicity. J. Mol. Cell. Cardiol. 29:1997;2915-2923.
11. Murray D.R., Prabhu S.D., Chandrasekar B. Chronic β-adrenergic stimulation induces myocardial proinflammatory cytokine expression. Circulation. 101:2000;2338-2341.
12. Oh H., Fujio Y., Kunisada K., Hirota H., Matsui H., Kishimoto T., Yamauchi-Takihara K. Activation of phosphatidylinositol 3-kinase through glycoprotein 130 induces protein kinase B and p70 S6 kinase phosphorylation in cardiac myocytes. J. Biol. Chem. 273:1998;9703-9710.
13. Patten M., Kramer E., Bunemann J., Wenck C., Thoenes M., Wieland T., Long C. Endotoxin and cytokines alter contractile protein expression in cardiac myocytes in vivo. Pflugers Arch. 442:2001;920-927.
14. Pulkki K.J. Cytokines and cardiomyocyte death. Ann. Med. 29:1997;339-343. (Review).
15. Rauchhaus M., Doehner W., Francis D.P., Davos C., Kemp M., Liebenthal C., Niebauer J., Hooper J., Volk H.D., Coats A.J.S., Anker S.D. Serum cytokine parameters and mortality in patients with chronic heart failure. Circulation. 102:2000;3060-3067.
16. Rump L.C., Schwertfeger E., Schaible U., Fraedrich G., Schollmeyer P. β2-Adrenergic receptor and angiotensin II receptor modulation of sympathetic neurotransmission in human atria. Circ. Res. 74(3):1994;434-440.
17. Saito H., Patterson C., Hu Z., Runge M.S., Tipnis U., Sinha M., Papaconstantinou J. Expression and self-regulatory function of cardiac interleukin-6 during endotoxemia. Am. J. Physiol. Heart Circ. Physiol. 279:2000;H2241-H2248.
18. Sano M., Fukuda K., Kodama H., Pan J., Saito M., Matsuzaki J., Takahashi T., Makino S., Kato T., Ogawa S. Interleukin-6 family of cytokines mediate angiotensin II-induced cardiac hypertrophy in rodent cardiomyocytes. J. Biol. Chem. 275:2000;29717-29723.
19. Straub R.H., Dorner M., Riedel J., Kubitza M., Van Rooijen N., Lang B., Schölmerich J., Falk W. Tonic neurogenic inhibition of interleukin-6 secretion from murine spleen caused by opioidergic transmission. Am. J. Physiol. 274:1998;R997-R1003.
20. Straub R.H., Herfarth H., Falk W., Andus T., Scholmerich J. Uncoupling of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis in inflammatory bowel disease? J. Neuroimmunol. 126:2002;116-125.
21. Swedberg K., Bristow M.R., Cohn J.N., Dargie H., Straub M., Wiltse C., Wright T.J. Moxonidine Safety and Efficacy (MOXSE) Investigators. Effects of sustained-release moxonidine, an imidazoline agonist, on plasma norepinephrine in patients with chronic heart failure. Circulation. 105(15):2002;1797-1803.
22. Thaik C.M., Calderone A., Takahashi N., Cheng D.L.F., Colucci W.S. Effects of inflammatory cytokines on growth and growth factor expression in cardiac myocytes and fibroblasts. Circulation. 92(suppl):1995;569-570.
23. Tsutamoto T., Hisanaga T., Wada A., Maeda K., Ohnishi M., Fukai D., Mabuchi N., Sawaki M., Kinoshita M. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high serum level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J. Am. Coll. Cardiol. 31:1998;391-398.
24. Yoshida K., Taga T., Saito M., Suematsu S., Kumanogoh A., Tanaka T., Fujiwara H., Hirata M., Yamagami T., Nakahata T., Hirabayashi T., Yoneda Y., Tanaka K., Wang W.Z., Mori C., Shiota K., Yoshida N., Kishimoto T. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc. Natl. Acad. Sci. USA. 93:1996;407-411.